Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
09/1993
09/16/1993WO1993017705A1 Selectively deglycosylated human immunodeficiency virus type 1 envelope vaccines
09/16/1993WO1993017700A1 Immune-enhancing agent for therapeutic use in immunocompromised hosts
09/16/1993WO1993017693A1 Albumin-iodine preservation of blood, tissues and biological fluids
09/16/1993WO1993017692A1 Dual action 2',5'-oligoadenylate antiviral derivatives and uses thereof
09/16/1993WO1993017684A2 Enantiomeric hydroxylated xanthine compounds
09/16/1993WO1993017676A1 Antifungal agents
09/16/1993WO1993017671A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria
09/16/1993WO1993017655A1 Topical aromatic releasing compositions
09/16/1993WO1993017633A1 Adhesive bandages, wound dressings, sutures, drapes, orthodontic rubber bands, toothbrushes, and the like
09/16/1993WO1993017108A3 Analogous peptides of the internal image of a viral protein
09/16/1993CA2383007A1 Helicobacter pylori proteins useful for vaccines and diagnostics
09/16/1993CA2131909A1 Selectively deglycosylated human immunodeficiency virus type i envelope vaccines
09/16/1993CA2131693A1 Antiviral nucleoside analogues
09/16/1993CA2131371A1 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents
09/16/1993CA2131024A1 Treatment and prophylaxis of diseases caused by parasites, or bacteria
09/16/1993CA2131010A1 Cyclic ketal derivatives
09/16/1993CA2130938A1 1-alkoxy-(2-alkoxy- or cycloalkoxy)-4-(cyclo thioalkyl- or cyclothioalkenyl)benzenes as inhibitors of cyclic amp phosphodiesterase and tumour necrosis factor
09/16/1993CA2130359A1 Compositions and methods for modulating rna
09/15/1993EP0560613A1 Antimicrobial carbapenem derivatives, their preparation and their therapeutic use
09/15/1993EP0560407A1 Pharmaceutically active compounds
09/15/1993EP0560389A1 Lactone with immunosuppressive activity
09/15/1993EP0560365A1 Cephalosporin derivative
09/15/1993EP0560275A1 Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients
09/15/1993EP0560274A1 Antiherpes peptide derivatives having a ureido N-terminus
09/15/1993EP0560269A1 Substituted pyrrolidine derivatives as HIV protease inhibitors
09/15/1993EP0560268A1 Substituted pipecolinic acid derivatives as HIV protease inhibitors
09/15/1993EP0560267A1 Isosteric antiherpes peptide derivatives
09/15/1993EP0560156A2 Pseudorabies virus polynucleotids and their use in the production of virus-resistant eucaryotic cells
09/15/1993EP0560149A1 BU-4641V, an antibacterial antiviral and antitumor antibiotic
09/15/1993EP0560147A1 16-Membered macrolide derivative having sustained antibacterial activity in plasma, synthesic intermediate thereof and process for producing the same
09/15/1993EP0559856A1 Antimicrobial preservation of platelets and blood factors
09/15/1993EP0559845A1 Use of compounds in preventing endotoxin shock
09/15/1993EP0559815A1 Optically active thiazoloisoindolinone derivatives with an antiviral action.
09/15/1993EP0559793A1 Hiv protease inhibitors
09/15/1993EP0559791A1 Treatment of topical infections
09/15/1993EP0559774A1 Individual stereoisomers of 7- 3-(1-aminoalkyl)-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents
09/15/1993EP0559752A1 Optical isomers of 7- 3-(1,1-dialkylmethyl-1-amino-1-pyrrolidinyl]-quinolones and naphthyridones as antibacterial agents
09/15/1993EP0559744A1 Combinations of vanilloid compounds and nucleoside antiviral compounds for treatment of herpes infections
09/15/1993EP0559647A1 Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase
09/15/1993EP0517836A4 Method and product for promoting hair growth and treating skin conditions
09/15/1993CN1022105C Process for preparing dihydro benzothiophene
09/14/1993US5245010 Polypeptide of herpes simplex virus vmw 65 protein
09/14/1993US5244893 Benzothiophene-2-carboxamide s,s-dioxides and use
09/14/1993US5244885 Vaginal douche
09/14/1993US5244653 Glycine anhydride dimethylol as a biocide and preservative
09/14/1993CA2091151A1 Retroviral protease inhibitors
09/14/1993CA1322172C Antiviral pharmaceutical compositions containing cyclodextrin
09/14/1993CA1322158C Uses of recombinant colony stimulating factor-1
09/12/1993WO1993024632A1 Hybrid siv/hiv-1 viral vectors and monkey model for aids
09/12/1993CA2135618A1 Vectors expressing hybrid viruses, methods of use and novel assays
09/12/1993CA2091486A1 Antimicrobial carbapenem derivatives, their preparation and their therapeutic use
09/08/1993EP0558944A2 RNA and DNA molecules for producing virus resistance
09/08/1993EP0558913A1 Improved pulsatile once-a-day delivery systems for minocycline
09/08/1993EP0558749A1 Antisense nucleic acid derivative
09/08/1993EP0558659A1 Tnf inhibitors
09/08/1993EP0558630A1 Retroviral protease inhibitors
09/08/1993EP0558603A1 Retroviral protease inhibitors
09/08/1993EP0558490A1 Portable ribozyme cassettes, dna sequences containing them, ribozymes encoded by these dna sequences, and compositions containing these ribozymes
09/08/1993EP0414847B1 Use of omeprazole as an antimicrobial agent
09/08/1993CN1075889A Silkworm medicine for antiviral silkworm diseases
09/07/1993US5243094 Derivatives of long chain fatty alcohols, their uses, particularly as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing them
09/07/1993US5243036 Process for obtaining polymers with antiviral activity
09/07/1993US5242924 Tetrazolyl-(phenoxy and phenoxyalkyl)-piperidinylpyridazines as antiviral agents
09/07/1993US5242908 Use of benzylphosphonic acid derivatives for the treatment of diseases caused by viruses
09/07/1993CA1322006C 2-oxo-1-{[(substituted sulfonyl)amino] -carbonyl}azetidines
09/07/1993CA1322002C 2-(heteroaryliumalkyl)phenyl carbapenem antibacterial agents
09/07/1993CA1322001C Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
09/05/1993CA2102518A1 Antifungal agents
09/02/1993WO1993017111A1 Hepatitis c virus peptides
09/02/1993WO1993017109A1 Ibv spike protein (2)
09/02/1993WO1993017108A2 Analogous peptides of the internal image of a viral protein
09/02/1993WO1993017105A1 Altered antibodies, products and processes relating thereto
09/02/1993WO1993017044A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections
09/02/1993WO1993017027A1 Novel therapeutical use of pyridylpyrrolothiazole carboxamide derivatives
09/02/1993WO1993017020A2 Therapeutic nucleosides
09/02/1993WO1993017003A1 Retroviral protease inhibitors
09/02/1993WO1993016726A2 Inactivated mycoplasma hyopneumoniae and uses therefor
09/02/1993WO1993016723A1 Purified vacuolating toxin from helicobacter pylori and methods to use same
09/02/1993WO1993016722A1 Antigens protective against echinococcus granulosus infection and vaccines containing such antigens
09/02/1993WO1993016703A1 Protein kinase c inhibitor
09/02/1993WO1993016693A1 Novel and prior art disulphides and their use in the control of helicobacter bacteria
09/02/1993WO1993014767A3 Pharmaceutical preparation based on rhamnolipid against dermatological diseases, e.g. papilloma virus infections
09/02/1993WO1993014760A3 Methods
09/02/1993WO1993013740A3 Antiparasitic oligonucleotides active against drug resistant malaria
09/02/1993CA2131028A1 Hepatitis c virus peptides
09/02/1993CA2129982A1 Inactivated mycoplasma hyopneumoniae and uses therefor
09/02/1993CA2129827A1 Analogous peptides of a viral protein internal image
09/02/1993CA2127545A1 New therapeutic application for pyridyl pyrrolo thiazole carboxamide derivatives
09/02/1993CA2117480A1 Directed human immune globulin for the prevention and treatment of staphylococcal infections
09/02/1993CA2117468A1 Ibv spike protein (2)
09/01/1993EP0558215A1 Novel methods and compounds for the preparation of carbacephems
09/01/1993EP0557467A1 Diagnostic testing for campylobacter jejuni or coli infection using antigens
09/01/1993EP0557455A1 Recombinant feline coronavirus s proteins
09/01/1993EP0557427A1 Human rotaviruses, vaccines and methods
09/01/1993EP0557388A1 Diagnosis and treatment of multiple sclerosis
09/01/1993EP0557383A1 Method of inhibiting transformation, growth and metastasis of cells in which purine metabolic enzyme activity is elevated
09/01/1993EP0557336A1 Use of 2h-1,2,4-benzothiadiazine-3(4h)-thion-1,1-dioxides as antiviral medicaments.
09/01/1993EP0557290A1 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss
09/01/1993CN1075632A Alkoxylated phenyl and coumarin derivatives and application thereof
09/01/1993CN1021967C Ouinoline derivatives and processes for preparation thereof
1 ... 1666 1667 1668 1669 1670 1671 1672 1673 1674 1675 1676 1677 1678 1679 1680 1681 1682 1683 1684 1685 1686 ... 1798